To mark World Sickle Cell Day, the Dominica-founded Sickle Cell Cares Foundation Inc. (SCCF) has made history by launching the Caribbean region’s first dedicated digital health platform for people living with Sickle Cell Disease (SCD), filling a long-standing gap in specialized care access across the Eastern Caribbean. The new platform, named SickleConnect, is built to give SCD patients user-friendly, on-the-go access to condition management tools via any smartphone or internet-connected device, according to an official press release from SCCF.
As defined by the U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute, Sickle Cell Disease is a group of inherited blood disorders that cause genetic mutations resulting in red blood cells taking on a rigid, sickle shape. Unlike flexible, round healthy red blood cells, these misshapen cells cannot move easily through blood vessels, often blocking blood flow and leading to debilitating health complications including recurring extreme pain crises and persistent chronic fatigue. This genetic trait is most common among populations of African descent; interestingly, carriers with one sickle cell gene and one normal gene do not develop the full disease, and the trait is linked to natural resistance against malaria.
For SCCF Founder and CEO Kellyn George, the launch of SickleConnect is deeply personal: George lives with HbSS sickle cell disease, and shared in a statement that the platform is exactly what she needed when she was growing up managing her condition. Every feature of the platform was designed specifically around the unique daily challenges SCD patients face, rather than adapting general health tools to fit their needs.
One of the platform’s core tools is a customizable pain monitoring system that lets users log every pain crisis, rate its severity on a standardized scale, and track potential environmental or lifestyle triggers that may precipitate episodes. For female patients, the tool adds the ability to map pain symptoms against menstrual cycles, helping identify consistent patterns and correlations that can inform long-term management.
SickleConnect also includes comprehensive medication management functionality: users can build personalized medication schedules, track their adherence to treatment plans, receive automatic reminders for prescription refills, and access evidence-based warnings about dangerous drug interactions common to frequently prescribed SCD medications including Hydroxyurea and Penicillin. To address the well-documented role of consistent hydration in reducing SCD complication frequency, the platform also includes a visual hydration tracker that guides users to hit the recommended daily intake of three liters of fluid, with clear progress indicators to help build sustainable habits.
A standout innovation is the platform’s AI-powered clinical reporting tool, which aggregates a user’s 30 days of self-tracked health data into a structured, clinician-friendly summary that can be directly shared with a patient’s haematologist. SCCF confirmed that this feature will remain completely free for all users during their first 30 days on the platform. Beyond self-management tools, SickleConnect also connects patients to direct care and support: users can book private one-on-one video consultations with SCD-specific counselors and advisors with lived experience of the condition. For emergency situations, the platform includes a one-tap Crisis SOS feature that sends an immediate alert with the user’s location to pre-designated contacts.
To foster peer connection and shared learning, SickleConnect hosts six moderated community chat rooms, where patients from across the Caribbean and the global Caribbean diaspora can connect, share personal management tips and experiences, and access curated educational resources.
SCCF emphasized the urgent public health need for this initiative: across populations of African and Caribbean descent, approximately one in every 500 people lives with Sickle Cell Disease, a condition that carries a high risk of severe pain crises, permanent organ damage, and drastically reduced life expectancy. Across Dominica and much of the Eastern Caribbean, access to specialized haematology care for SCD patients has long been extremely limited. Before SickleConnect’s launch, there was no regional digital health platform purpose-built to address the unique needs of this patient population.
SCCF anticipates that the new platform will transform care across the region: it is expected to improve individual disease management outcomes, strengthen fragmented patient support networks, and close critical gaps in access to specialized care for underserved communities. SickleConnect is available immediately at no cost to users, accessible via any web browser at app.sicklecellcares.org. It can also be saved as a native-style app to both iPhone and Android devices without requiring a download from traditional app stores.